Karishma

A case of cyclophosphamide-induced posterior reversible encephalopathy syndrome: is it dose-related side effect?

• Authors Details :  
• Theeb Osama Sulaiman,  
• Ahmed K A Yasin,  
• Abdellatif Ismail

Journal title : Yemen Journal of Medicine

Publisher : Mansa STM Publishers

Online ISSN : 2583-4614

Page Number : 103-107

Journal volume : 1

Journal issue : 2

18 Views Case Report

We reported a case of cyclophosphamide (CYP)-induced posterior reversible encephalopathy syndrome (PRES) in a 26-year-old previously healthy male patient who was presented to the emergency department with a history of fever, shortness of breath, and hemoptysis. After extensive investigations, including bronchoscopy and autoimmune screening, he was diagnosed with renalpulmonary syndrome. The diagnosis of CYP-related PRES was based on the development of neurological clinical picture supported by magnetic resonance imaging findings. The dose of CYP was decreased to 75 mg/day, and the patient’s symptoms improved after 3 days.

Article DOI & Crossmark Data

DOI : https://doi.org/10.32677/yjm.v1i2.3684

Article Subject Details

• Nephrology
• Neurology
• Pharmacology

Article Keywords Details

• Cyclophosphamide
• Posterior reversible encephalopathy syndrome
• Renal pulmonary disease
• Antineutrophil cytoplasmic antibody

Article File

Full Text PDF

---

More Article by Karishma